Peer review reports
From: B7-H3 targeted CAR-T cells show highly efficient anti-tumor function against osteosarcoma both in vitro and in vivo
Original Submission |
4 May 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
31 May 2022 |
Reviewed |
Reviewer Report
|
14 Sep 2022 |
Reviewed |
Reviewer Report
|
4 Oct 2022 |
Author responded |
Author comments - Xiaoli Tian
|
Resubmission - Version 5 |
4 Oct 2022 |
Submitted |
Manuscript version 5
|
24 Oct 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
25 Oct 2022 |
Editorially accepted |
|
2 Nov 2022 |
Article published |
10.1186/s12885-022-10229-8
|
Learn about peer review